Healthcare provider profile · identity verified

Adrian Lemar James, M.D.

Internal Medicine · OAKLAND, CA · NPI 1356495261

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1230	169
Albuterol Sulfate Hfa	Albuterol Sulfate	460	124
Amlodipine Besylate	Amlodipine Besylate	393	140
Atorvastatin Calcium	Atorvastatin Calcium	335	118
Gabapentin	Gabapentin	335	77
Hydrochlorothiazide	Hydrochlorothiazide	256	84
Lisinopril	Lisinopril	255	80
Losartan Potassium	Losartan Potassium	232	73
Oxycodone Hcl	Oxycodone Hcl	216	23
Ibuprofen	Ibuprofen	207	55
Metformin Hcl	Metformin Hcl	186	62
Triamcinolone Acetonide	Triamcinolone Acetonide	136	44
Simvastatin	Simvastatin	128	41
Fluticasone Propionate	Fluticasone Propionate	117	41
Trazodone Hcl	Trazodone Hcl	103	25
Omeprazole	Omeprazole	101	36
Furosemide	Furosemide	99	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	98	26
Famotidine	Famotidine	96	39
Tizanidine Hcl	Tizanidine Hcl	90	27
Ozempic	Semaglutide	89	17
Promethazine Hcl	Promethazine Hcl	88	31
Potassium Chloride	Potassium Chloride	84	26
Tramadol Hcl	Tramadol Hcl	82	17
Ventolin Hfa	Albuterol Sulfate	78	27
Methadone Hcl	Methadone Hcl	71	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	70	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	66	12
Levothyroxine Sodium	Levothyroxine Sodium	65	21
Diclofenac Sodium	Diclofenac Sodium	64	24
Meloxicam	Meloxicam	58	20
Glipizide	Glipizide	55	17
Metoprolol Succinate	Metoprolol Succinate	54	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	14
Atenolol	Atenolol	48	14
Clopidogrel	Clopidogrel Bisulfate	47	19
Breo Ellipta	Fluticasone/Vilanterol	46	15
Levetiracetam	Levetiracetam	46	14
Naproxen	Naproxen	46	15
Pantoprazole Sodium	Pantoprazole Sodium	46	15
Baclofen	Baclofen	45	14
Buspirone Hcl	Buspirone Hcl	43	suppressed
Carvedilol	Carvedilol	43	22
Enalapril Maleate	Enalapril Maleate	43	15
Nitroglycerin	Nitroglycerin	43	20
Zolpidem Tartrate	Zolpidem Tartrate	43	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	41	13
Eliquis	Apixaban	41	15
Metoprolol Tartrate	Metoprolol Tartrate	41	12
Nifedipine Er	Nifedipine	40	11
Lorazepam	Lorazepam	39	suppressed
Chlorthalidone	Chlorthalidone	38	13
Hydroxyzine Hcl	Hydroxyzine Hcl	38	suppressed
Hydrocortisone	Hydrocortisone	37	15
Acetaminophen-Codeine	Acetaminophen With Codeine	36	suppressed
Acyclovir	Acyclovir	36	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	11
Latanoprost	Latanoprost	33	11
Clotrimazole	Clotrimazole	32	11
Allopurinol	Allopurinol	30	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Colchicine	Colchicine	29	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	13
Meclizine Hcl	Meclizine Hcl	28	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Naloxone Hcl	Naloxone Hcl	27	15
Prednisone	Prednisone	27	20
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Lidocaine	Lidocaine	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Carisoprodol	Carisoprodol	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Jardiance	Empagliflozin	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	22	suppressed
Breyna	Budesonide/Formoterol Fumarate	21	suppressed
Linzess	Linaclotide	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	11
Novolog Flexpen	Insulin Aspart	20	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	19	suppressed
Risperidone	Risperidone	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Alprazolam	Alprazolam	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Diazepam	Diazepam	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Azithromycin	Azithromycin	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Tivicay	Dolutegravir Sodium	12	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error